Akari Therapeutics PLC AKTX
9.76
(0.30)
(2.98%)
as of 25 Sep
- Market cap
- $17.6M
- P/E
- 0.0×
Follow AKTX
Growth Flags
show if company had growth for consecutive years
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
3.90 | 2.43 | 1.52 | 1.00 | 2.79 | 1.91 | 1.15 | 0.95 | 0.15 | 0.44 |
Net Debt/EBITDA |
1.62 | 0.74 | 0.18 | 0.15 | 0.78 | 0.54 | 0.57 | 0.23 | 0.09 | 0.27 |
Debt/Assets |
0.00% | 0.00% | 22.95% | 48.10% | 0.00% | 0.00% | 0.00% | 0.00% | 1.38% | 1.41% |
Debt/Equity |
0.00 | 0.00 | 0.59 | 410.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
1.36 | 0.89 | 1.37 | 0.77 | 0.99 | 1.08 | 1.21 | 1.64 | 0.63 | 0.61 |
Capex/Depreciation |
(1.37) | (0.87) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (43.81%) | (138.13%) | (162.51%) | (1,080.27%) | (363.75%) | (233.27%) | (483.23%) | (1,281.43%) | (179.92%) | (68.43%) | |
| (31.34%) | (94.49%) | (88.82%) | (232.21%) | (162.03%) | (132.74%) | (139.31%) | (110.06%) | (72.08%) | (35.14%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (66.73%) | (45.48%) |
Return on Tangible Assets |
(53.39%) | (207.98%) | (644.14%) | 74,872.00% | (182.55%) | (314.99%) | (1,000.45%) | 4,118.52% | 116.71% | 251.10% |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.94 | 0.89 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(1,678.86) | (2,027.92) | (1,169.96) | (564.12) | (429.12) | (350.96) | (275.34) | (134.25) | (42.04) | (12.56) |
Cash per Share |
3,001.42 | 1,801.71 | 282.18 | 250.29 | 355.84 | 174.33 | 169.65 | 31.41 | 8.90 | 6.25 |
Shareholders Equity per Share |
2,319.90 | 1,099.62 | 161.21 | 0.33 | 237.58 | 103.44 | 22.93 | (1.87) | 74.44 | 33.66 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2,319.90 | 1,099.62 | 161.21 | 0.33 | 237.58 | 103.44 | 22.93 | (1.87) | 74.44 | 33.66 |
Free Cash Flow |
(24.68) | (31.64) | (22.58) | (12.92) | (16.95) | (18.85) | (21.50) | (16.43) | (12.55) | (10.57) |
Working Capital |
33.92 | 16.96 | 2.54 | (0.03) | 9.36 | 5.53 | 1.77 | (0.24) | (16.96) | (6.89) |
Capital Expenditures |
(0.05) | (0.04) | — | — | — | — | — | — | — | — |
Net Current Asset Value |
33.86 | 16.92 | 2.54 | (0.03) | 9.36 | 5.53 | 1.77 | (0.24) | (25.38) | (14.10) |
| Other line items | ||||||||||
Quick Ratio |
3.77 | 2.37 | 1.11 | 0.89 | 2.69 | 1.54 | 1.10 | 0.84 | 0.13 | 0.43 |
Depreciation/Fixed assets |
0.68 | 0.76 | 1.75 | 3.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Cash ROIC |
(31.55%) | (69.94%) | (217.32%) | (145.92%) | (72.31%) | (126.35%) | (142.97%) | (454.42%) | (49.05%) | (30.84%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(1,675.14) | (2,025.56) | (1,169.96) | (564.12) | (429.12) | (350.96) | (275.34) | (134.25) | (42.04) | (12.56) |
Capex per Share |
(3.73) | (2.37) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
3.27 | 2.09 | 1.78 | 1.41 | 2.30 | 2.58 | 1.37 | 1.31 | 7.04 | 10.59 |
Average Assets |
57.88 | 37.46 | 18.54 | 7.25 | 10.54 | 13.13 | 12.74 | 9.09 | 27.46 | 49.23 |
Average Common Equity |
41.41 | 25.63 | 10.13 | 1.56 | 4.70 | 7.47 | 3.67 | 0.78 | 11.00 | 25.28 |
Capex to Sales |
0.00 | 0.00 | — | — | — | — | — | — | — | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates